The next generation: myopia controlling spectacle lenses
Date: 26/09/2022 (AEST)
Venue: To be advised, QLD, 4101
Provider: Essilor Australia and New Zealand Pty Ltd
Contact: Tim Thurn, [E] tim.thurn@essilor.com.au, [P] 0438 335 877
Learning Objectives
- Describe scientific research outcomes of new myopia controlling spectacle lenses in terms of efficacy and visual function
- Determine clinical pathways for prescribing new myopia controlling spectacles, including managing outcomes
- Provide details of the nature of the Essilor Stellest lens, its prescribing and fitting as well as the outcomes of the 2 yr clinical trial
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| The next generation: myopia controlling spectacle lenses |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1 |
| Name |
|---|
| Essilor Stellest Lenses |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |